Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Ibrahimi, OA

Class:IdPerson:190246
_displayNameIbrahimi, OA
_timestamp2007-02-02 20:40:44
created[InstanceEdit:190250] de Bono, B, 2006-12-18 15:42:29
firstnameOmar A
initialOA
modified[InstanceEdit:192405] D'Eustachio, P, 2007-02-02 20:38:51
surnameIbrahimi
(author)[LiteratureReference:190251] Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
[LiteratureReference:191519] Structural basis for fibroblast growth factor receptor activation
[LiteratureReference:443238] Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
[LiteratureReference:1307940] Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
[LiteratureReference:2011820] Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity
[LiteratureReference:2029802] Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities
[LiteratureReference:2033242] Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma
[Change default viewing format]
No pathways have been reviewed or authored by Ibrahimi, OA (190246)